ANTIBODIES TO CD40

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20100098694A1
SERIAL NO

12576459

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to antibodies and antigen-binding portions thereof that specifically bind to CD40, preferably human CD40, and that function as CD40 agonists. The invention also relates to human anti-CD40 antibodies and antigen-binding portions thereof. The invention also relates to antibodies that are chimeric, bispecific, derivatized, single chain antibodies or portions of fusion proteins. The invention also relates to isolated heavy and light chain immunoglobulins derived from human anti-CD40 antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human anti-CD40 antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions for diagnosis and treatment. The invention also provides gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-CD40 antibodies. The invention also relates to transgenic animals comprising nucleic acid molecules of the present invention.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AMGEN FREMONT INCFREMONT CA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bedian, Vahe East Lyme, US 59 864
Corvalan, Jose Foster City, US 18 891
Feng, Xiao Union City, US 62 1106
Gladue, Ronald P Stonington, US 33 706
Jia, Xiao-Chi San Mateo, US 78 1901

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation